Sarilumab
Sanofi,regeneron
[]
just so good to see pmr on the plenary stage at #acr22, after #eular2022 too saphyr study: sarilumab allows for
- a quicker steroid wean &amp; less toxicity
- but also far more disease remission, quicker symptom resolution, better quality of life game-changing.
abst1676 
Rheumatologist and clinical pharmacologist, world traveller pretences on the upswing, sometimes podcast host for @austprescriber and others. All opinions my own